沉默CACYBP通过CDK1抑制抑制肺腺癌的生长
Ge Wen1, Shaoqing Niu2, Shiqi Mei3
1Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China; Department of Radiation Oncology; Guangdong Provincial Key Laboratory of Major Obstetric Diseases; Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology; The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Biomolecules & biomedicine
|April 1, 2025
概括
环素结合蛋白 (CACYBP) 通过与CDK1相互作用来激活PI3K/AKT通路,促进肺腺癌 (LUAD). 准CACYBP可能为LUAD患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 环素结合蛋白 (CACYBP) 与癌症的发展有关.
- 在肺腺癌 (LUAD) 中CACYBP的特定作用尚不清楚.
研究的目的:
- 为了研究CACYBP在LUAD中的生物功能和分子机制.
- 评估CACYBP作为潜在的治疗标和LUAD的预后生物标志物.
主要方法:
- 免疫组织化学检测CACYBP在LUAD组织中的表达.
- 在体外和体内实验中使用CACYBP在LUAD细胞系和小鼠模型中的敲除.
- 西方涂抹,qRT-PCR,共免疫沉和途径抑制试验以阐明分子机制.
主要成果:
- 在LUAD中,CACYBP表达升高,与晚期和不良预后相关.
- 在CACYBP的淘汰中,抑制了LUAD的进展,转移和瘤性,同时促进了亡.
- CACYBP与CDK1直接相互作用,CDK1过度表达促进了LUAD恶性瘤.
- 通过CDK1介导的LUAD生长取决于PI3K/AKT通路.
结论:
- CACYBP在LUAD中起到瘤促进作用,部分是通过CDK1-介导PI3K/AKT通路的激活.
- CACYBP代表了肺腺癌的潜在治疗标和预后生物标志物.
相关概念视频
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K


